DJIA 17,804.80 26.65 0.15%
NASDAQ 4,765.38 16.98 0.36%
S&P 500 2,070.65 9.42 0.46%
market minute promo

Emergent BioSolutions (NYSE: EBS)

27.05 0.07 (0.26%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

EBS $27.05 0.26%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $26.98
Previous Close $26.98
Daily Range $26.40 - $27.85
52-Week Range $19.31 - $28.48
Market Cap $1.0B
P/E Ratio 46.52
Dividend (Yield) $0.00 (0.0%)
Volume 706,975
Average Daily Volume 200,134
Current FY EPS $1.16

Sector

Healthcare

Industry

Drugs

Emergent BioSolutions (EBS) Description

Emergent BioSolutions makes the only FDA-approved anthrax vaccine. Website: http://www.emergentbiosolutions.com/

News & Commentary Rss Feed

3 Fast-Growing Biotech Stocks To Buy in December

You don't want to miss out on these tiny biotechs expected to see earnings grow sharply in 2015.

Emergent BioSolutions Buys EV-035 Series from Evolva - Analyst Blog

Worried About a Market Crash? These 3 Stocks Soared During the Great Recession

Catamaran Corp., Cantel Medical, and Emergent BioSolutions all gained ground during the Great Recession, suggesting that they might be good stocks to watch if markets head south.

Emergent BioSolutions Beats on Q3 Earnings, Guidance Up - Analyst Blog

Emergent BioSolutions Inc Busts Through Guidance. Sort of.

Emergent BioSolutions' upfront payment from its deal with MorphoSys caused a large increase in revenue in the third quarter.

Emergent BioSolutions' (EBS) CEO Dan Abdun-Nabi on Q3 2014 Results - Earnings Call Transcript

Emergent BioSolutions (EBS) Q3 2014 Results - Earnings Call Webcast

Ebola: The making of a $1 billion drug

3 Biotech Stocks the Market Hates May Rally

These three biotech companies may benefit if short sellers reverse course.

Amicus Reports Additional Positive Data on Fabry Therapy - Analyst Blog

See More EBS News...

EBS's Top Competitors

EBS $27.05 (0.26%)
Current stock: EBS
AMGN $170.17 (1.00%)
Current stock: AMGN
GILD $108.45 (2.76%)
Current stock: GILD
BIIB $360.67 (1.97%)
Current stock: BIIB